Luisa Bopp - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Luisa Bopp

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

The British Journal of Dermatology|September 18, 2025

Metformin in Necrobiotic XanthogranulomaHenning Klapproth, Manuel Huerta Arana, Jan W Lackmann, et al.

Iscience|May 13, 2024

Glutamine promotes human CD8<sup>+</sup> T cells and counteracts imiquimod-induced T cell hyporesponsivenessLuisa Bopp, Maria Lopéz Martinez, Clara Schumacher, et al.

Science Advances|May 29, 2026

A STAT1/ETC/GBP1 axis represents a potential therapeutic target for noncommunicable granulomatous skin diseaseManuel Huerta Arana, Henning Klapproth, Michal A Stanczak, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

The British Journal of Dermatology|September 18, 2025

Metformin in Necrobiotic XanthogranulomaHenning Klapproth, Manuel Huerta Arana, Jan W Lackmann, et al.

Iscience|May 13, 2024

Glutamine promotes human CD8<sup>+</sup> T cells and counteracts imiquimod-induced T cell hyporesponsivenessLuisa Bopp, Maria Lopéz Martinez, Clara Schumacher, et al.

Science Advances|May 29, 2026

A STAT1/ETC/GBP1 axis represents a potential therapeutic target for noncommunicable granulomatous skin diseaseManuel Huerta Arana, Henning Klapproth, Michal A Stanczak, et al.

Pageof 2